Sign in to continue:

Thursday, April 23rd, 2026

Pinnacle Financial Partners Delivers Strong Q1 2026 Results Post-Synovus Merger with Robust Loan Growth and Solid Credit Quality

Pinnacle Financial Partners (PNFP) Reports Strong Q1 2026 Results Following Synovus Merger

Pinnacle Financial Partners (PNFP) Delivers Standout First Quarter 2026 Results After Transformative Synovus Merger

Key Highlights of the Report

  • Successful Merger Integration: Pinnacle Financial Partners (PNFP) completed its significant merger with Synovus Financial Corp. on January 1, 2026. All purchase accounting adjustments remain preliminary as of March 31, 2026, and are subject to further updates until the measurement period is closed.
  • Impressive Financial Performance in Q1 2026: The combined entity reported robust loan and deposit growth, top-tier profitability, disciplined expense management, and industry-leading credit quality metrics.
  • Continued Revenue Producer Hiring: PNFP maintained its disciplined banker hiring model post-merger, adding 50 revenue producers in Q1 2026, with 37 additional hires or offers extended since quarter-end. This is a strong driver for future organic growth.
  • Solid Capital Position Maintained: PNFP’s Common Equity Tier 1 (CET1) ratio ended the quarter at 9.83%, in line with expectations and with a bias toward the lower end of its targeted range (10.25%–10.75%), ensuring capacity to support ongoing growth.
  • Updated 2026 Outlook: Initial 2026 guidance calls for 9–11% loan growth (excluding Day 1 accounting loan mark), 8–10% deposit growth, adjusted non-interest revenue of \$1.10–\$1.15 billion, and BHG investment revenue of \$105–\$115 million.
  • Realization of Merger Synergies: PNFP expects to realize 40% of the targeted \$250 million in net cost savings during 2026, with the majority of merger-related expense synergies already recognized in the first quarter.

Detailed Q1 2026 Financial and Operating Results

Strong Loan and Deposit Growth

  • Loans: Period-end loans (excluding purchase accounting loan mark) grew \$2.1 billion or 10% annualized on a combined basis versus Q4 2025, with growth diversified across geographic regions and specialty lending lines. Asset-backed finance, specialty finance, and corporate/investment banking contributed meaningfully.
  • Deposits: Period-end deposits (excluding brokered deposits) increased \$1.4 billion or 6% annualized, with core deposit growth of \$1.9 billion or 8% annualized, led by both geographic and specialty deposit lines.

Revenue and Profitability

  • Reported Revenue: \$1.217 billion for Q1 2026.
  • Adjusted Non-Interest Revenue: \$282 million, up over 20% year-over-year, with core banking, wealth management, and capital markets fees showing robust growth.
  • Diluted Earnings Per Share (EPS): \$0.89 reported; Adjusted Diluted EPS: \$2.39, reflecting the impact of merger-related charges.
  • Net Interest Income: \$933 million, with net interest margin (NIM) expanding to 3.53%, largely due to accretable marks from the merger.

Expense and Efficiency Management

  • Total Non-Interest Expense: \$952 million, including \$275 million in merger-related charges, of which \$70 million were equity acceleration costs.
  • Efficiency Ratio (Tax Equivalent): 77% (elevated due to merger charges); Adjusted Tangible Efficiency Ratio: 51%, in line with pre-merger performance.
  • Headcount Reduction: Down 2% quarter-over-quarter on a combined basis, reflecting realized merger synergies.

Credit Quality Remains Excellent

  • Net Charge-Offs to Average Loans: 0.23% in Q1 2026, in line with expectations. The modest increase was attributed to two previously-rated senior housing relationships with specific reserves and anticipated resolution in 2026.
  • Non-Performing Assets (NPAs) to Loans + ORE: 0.58%, reflecting disciplined credit selection and strong asset quality.
  • Allowance for Credit Losses (ACL): \$1.014 billion, or 1.19% of total loans.

Capital and Liquidity

  • CET1 Ratio: 9.83%, with management focused on supporting CET1 to achieve the low end of the targeted range while also pursuing growth objectives.
  • Peer Benchmarking: PNFP’s capital ratios are competitive with peers, and the bank anticipates a pro forma benefit of approximately 60 basis points from the proposed Standardized Approach for Risk-Weighted Assets (RWA) once implemented.
  • Liquidity: Ample liquidity with \$30.9 billion of available funding sources and a diversified funding base.

Merger Integration and Synergy Realization

  • Merger-Related Expense Synergies: Targeted at \$250 million, with 40% expected to be realized in 2026, 75% by 2027, and full run-rate by 2028. The majority of 2026 synergies were achieved in Q1.
  • Non-Recurring Merger Charges: Estimated at \$720 million, with \$275 million recognized in Q1 2026 and the remainder expected through 2027.
  • Operational Conversion: Scheduled for March 2027.

Revenue Producer Hiring and Business Model

  • Banker Hiring: A hallmark of PNFP’s strategy, the firm recruited 50 new revenue producers in Q1 2026 and maintains a strong pipeline, reinforcing its unique, disciplined, and culture-driven model with a focus on experienced talent and long recruiting cycles.
  • Revenue Synergy Progress: The merger has already begun to unlock revenue synergies across capital markets, specialty lending, and treasury management. Internal estimates indicate \$60–\$70 million in revenue opportunity from expanded swap lines, arranger fees, and specialty business lines.

2026 Outlook and Guidance (Potentially Price-Sensitive)

  • Loan Growth: 9–11% (excluding Day 1 purchase accounting loan mark), to \$106.5–\$108.5 billion.
  • Deposit Growth: 8–10%, to \$91.0–\$93.0 billion.
  • Adjusted Non-Interest Revenue: \$1.10–\$1.15 billion for the year.
  • BHG Investment Revenue: \$105–\$115 million.
  • Net Interest Margin (NIM): Expected to remain around 3.50% in 2026, with no interest rate cuts assumed for the year.
  • Net Charge-Offs/Average Loans: 0.20–0.25%, assuming a stable economic environment.
  • Adjusted Non-Interest Expense: Guidance is for relatively flat expense levels from Q1 2026 through the rest of the year, even as cost savings are realized.
  • Capital Target: CET1 in the 10.25–10.75% range, with a current bias toward the lower half of the range.

Other Noteworthy Items for Shareholders

  • Purchase Accounting Marks: As of March 31, 2026, the remaining accretable purchase accounting loan marks are \$694 million, subject to adjustment as integration continues.
  • Non-GAAP Measures: The company disclosed substantial use of non-GAAP metrics for comparability and management analysis, with detailed reconciliations provided in the appendix.
  • Expense Details: Merger-related costs in Q1 included equity acceleration and intangible amortization, which are not expected to recur at the same levels in future quarters.
  • Credit and Portfolio Diversification: The loan portfolio is well-diversified geographically and by asset class, with low concentrations in riskier segments. Non-depository financial institution (NDFI) exposure remains conservative and well-monitored.
  • Balance Sheet Management: The bank maintains a balanced mix of fixed- and variable-rate assets, active interest rate hedging, and robust liquidity and capital management.

Potentially Price-Sensitive Information

  • PNFP’s execution of merger synergies ahead of schedule and strong guidance for 2026—particularly for loan and deposit growth, profitability, and cost control—could positively impact investor sentiment and share price.
  • The robust post-merger performance, with strong credit quality, capital levels, and strategic hiring, positions the company for ongoing outperformance relative to peers.
  • Shareholders should monitor any further updates to purchase accounting adjustments, finalization of merger accounting, and realization of additional cost and revenue synergies, as these could further influence future results.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult with their financial advisor before making investment decisions. All forward-looking statements are subject to risks and uncertainties as described in the company’s filings and may differ materially from actual results.


View Pinnacle Financial Partners, Inc. Historical chart here



Aldeyra Therapeutics, Inc. 8-K SEC Filing April 2026 – Company Information, Address, and Trading Details

Aldeyra Therapeutics, Inc. Terminates Hercules Credit Facili...

Ranpak Holdings 2025 10-K Report: Sustainable Packaging, Automation Growth, and Market Strategy Overview

Ranpak Holdings Corp. 2025 Annual Report: Key Investor Takea...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today